Search results
Results From The WOW.Com Content Network
Alcon offices in Johns Creek, Georgia. Alcon Inc. (German: Alcon AG) is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people. [2]
By the mid-1990s, Alcon’s 150-acre campus in south Fort Worth was home to nine buildings and 2,500 employees, including hundreds of research scientists, manufacturing workers and managers.
Dallas Fort Worth International Airport (IATA: DFW, ICAO: KDFW, FAA LID: DFW) is the primary international airport serving the Dallas–Fort Worth metroplex and the North Texas region, in the U.S. state of Texas. It is the largest hub for American Airlines, which is headquartered near the airport, [ 2 ] and is the third-busiest airport in the ...
50 years later: How DFW Airport became an engine of growth for booming Dallas-Fort Worth. Eleanor Dearman. January 12, 2024 at 4:00 AM. It was 1973, and Grapevine Mayor William Tate was 31 and the ...
Southwest Airlines headquarters in Dallas. Comerica Bank Tower. The following are the Fortune 500 companies headquartered in the Dallas–Fort Worth metroplex: [2] 9 McKesson (Irving) 13 AT&T (Dallas) 54 Energy Transfer Partners (Dallas) 73 Caterpillar (Irving) 114 American Airlines Group (Fort Worth)
Alcon Laboratories, already one of the largest employers and taxpayers in Tarrant County, is exploring a 250,000-square-foot expansion. Alcon Laboratories, already one of the largest employers and ...
1,951. Concrete. Greater Southwest International Airport (IATA: GSW, ICAO: KGSW), originally Amon Carter Field (ACF), was a commercial airport serving Fort Worth, Texas, from 1953 until 1974. Dallas Fort Worth International Airport (DFW) opened in 1974 a few miles north to replace Greater Southwest and Dallas Love Field as a single airport for ...
The total cost to Novartis for the 77% stake in Alcon was $38.7 billion ($168 per share). In the deal's first phase, Novartis acquired a 25% stake in Alcon from Nestlé for $10.4 billion in July 2008.